More documentary evidence has emerged on the Health Ministry’s disastrous “fast-track” emergency procurement scheme that led to counterfeit drugs entering public sector hospitals.

Letters between key officials show the plan was in place as early as September last year. That month, a Health Ministry Additional Secretary wrote to the Deputy Director General of the Medical Supplies Division (MSD) stating that it was decided at a meeting chaired by former Health Minister Keheliya Rambukwella to buy drugs using the Indian credit line (ICL) through private suppliers.

The purchase would be under an “emergency procurement method”, it said, adding that pending orders must be disregarded.

This meant that, even if required stocks were on the way, the Health Ministry would farm out additional contracts under the ICL to handpicked suppliers. And it would be done through a new system that a small coterie of officials—with the Health Minister’s endorsement—had floated to facilitate walk-in, unsolicited offers from unvetted suppliers, bypassing the national drug regulatory process.